SSIEM 2024 was the annual meeting of the Society for the Study of Inborn Errors of Metabolism (SSIEM). This in-person event was held in Porto, Portugal.
Travere at SSIEM Symposim
Travere Therapeutics was excited to participate in the event and engage with metabolic experts from around the world.
Program
Pegtibatinase, an investigational enzyme replacement therapy for classical homocystinuria (HCU): design of the HARMONY and ENSEMBLE Phase 3 studies – PO-072
Speakers: François Maillot; Janet Thomas; Tawfeg Ben-Omran; Harvey Levy; Stephan vom Dahl; Clint Lovell; Sagar Vaidya; Can Ficicioglu
Type: Poster
Contact Your Travere MSL
Our Medical Science Liaisons (MSLs) are available to answer questions and provide support on Travere products.
Contact an MSLCOMPOSE® Phase 1/2, dose-escalation Cohort 7 design: safety of pegtibatinase in children aged ≥5–<12 years with classical homocystinuria (HCU) – EP-013
Speakers: François Feillet; Ellen Crushell; Janet Thomas; Tawfeg Ben-Omran; Harvey Levy; Clint Lovell; Cheryl Wong Po Foo; Can Ficicioglu
Type: e-poster
MA-DS-24-0018 | January 2025